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Abstract 9 
 10 
Staphylococcus aureus biofilm-related infections are of clinical concern due to the capability of 11 
bacterial colonies to adapt to a hostile environment. The present study investigated the capability of 12 
the acute phase protein alpha 1-acid glycoprotein (AGP) to a) disrupt already established S. aureus 13 
biofilm and b) interfere with the biofilm de novo production by using Microtiter Plate assay (MtP) on 14 
field strains isolated from infected quarters by assessing. The present study also investigated whether 15 
AGP could interfere with the expression of bacterial genes related to biofilm formation (icaA, icaD, 16 
icaB, and icaC) and adhesive virulence determinants (fnbA, fnbB, clfA, clfB, fib, ebps, eno) by 17 
quantitative real-time PCR (qPCR). The results provided the evidence that AGP could disrupt the 18 
biofilm structure only when it was already developed, but could not prevent the de novo biofilm 19 
formation. Moreover, AGP could interfere with the expression levels of genes involved in biofilm 20 
formation in a dose- and strain-dependent way, by upregulating, or downregulating, icaABC genes 21 
and fnbB, respectively. The results presented in this study provide new insights about the direct 22 
antibacterial activity of AGP in bovine milk. It remains to be demonstrated the molecular bases of 23 
AGP mechanism of action, in particular for what concerns the scarce capability to interact with the 24 
de novo formation of biofilm. 25 
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1. Introduction 30 
Mastitis has a deep impact on bovine dairy farm economy due to production losses, culling and 31 
treatment costs (Hogeveen and Van Der Voort, 2017). The main cause of mastitis is the development 32 
of an intramammary infection caused by bacteria, among which Staphylococcus (S.) aureus is one of 33 
most frequently isolated pathogens (Rainard et al., 2018). S. aureus is contagious, persistent in the 34 
bovine mammary gland, has a high colonization attitude of skin and mammary gland mucosal 35 
epithelia and is often low responsive to antibiotic therapy (Rainard et al., 2018). A significant risk 36 
factor in S. aureus infections is its ability to form a syntrophic consortium called biofilm within a 37 
self-produced matrix of extracellular polymeric substances (EPS). The production of biofilm is a 38 
strictly coordinated process by which planktonic bacteria switch from free-floating forms to sessile 39 
anchored cells embedded in self-produced EPS (Fox et al., 2005). Biofilm development is related to 40 
environmental signals and communication systems, that reflects on specific gene expression (Hall 41 
and Mah, 2017). In S. aureus, the switch from planktonic to sessile forms is controlled by quorum-42 
sensing proteins encoded by the agrABCD operon, whose abundance is related to virulence and 43 
pathogenicity(Antunes et al., 2010). Biofilm development further requires the expression of the gene 44 
cluster icaADBC, that produce polysaccharide intercellular adhesin (PIA), composed of β-1,6-linked 45 
N-acetylglucosamine with partially deacetylated residues (Arciola et al., 2005). Of pivotal importance 46 
for biofilm formation is the adhesion/colonization of biotic/abiotic surfaces related to the expression 47 
of microbial surface proteins that recognize adhesive matrix molecules (MSCRAMMs) such as 48 
laminin (eno), fibronectin A and B (fnbA, fnbB), collagen (cna), fibrinogen (fib) and clumping factor 49 
(clfA, clfB). Most of S. aureus isolated from subclinical mastitis are biofilm producers (Rainard et al., 50 
2018), and a recent study provided the evidence that S.aureus biofils can develop in bovine udder 51 
(Schönborn and Krömker, 2016). 52 
Alpha1-acid glycoprotein (AGP - Orosomucoid) is an acute phase protein and is as such it belongs to 53 
a group of structurally un-related proteins whose serum concentration changes during systemic 54 
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reaction of inflammation (Ceciliani and Lecchi, 2019). AGP fulfils at least two major sets of 55 
functions: on the one hand, it is one of the most important serum binding proteins for small 56 
hydrophobic molecules. On the other hand, AGP is an immunomodulatory protein, reducing the 57 
collateral damages on tissues involved in the inflammatory process (Lecchi et al., 2008, 2013; Rinaldi 58 
et al., 2008). Although the main source of AGP, as most of Acute Phase Proteins (APPs), is the liver. 59 
AGP expression is ubiquitous, and its coding mRNA was found in most of the bovine tissues and 60 
fluids where it was searched for (Lecchi et al., 2009), including milk. AGP is produced in the 61 
mammary gland (Ceciliani et al., 2005) and/or carried into the milk by neutrophils (Ceciliani et al., 62 
2007a), where it is stored in secondary granules and it is exocytosed after pro-inflammatory challenge 63 
(Rahman et al., 2008). Beside immunomodulatory activities, AGP is able to provide a direct 64 
antibacterial role, being active against Mycoplasma (Athamna et al., 1996), Bacillus anthracis 65 
(Shemyakin et al., 2005) and Klebsiella (Hochepied et al., 2000). To the best of the knowledge of the 66 
authors, the activity of AGP on biofilm formation was not explored so far. The aim of this study was 67 
to cover this gap by exploring whether AGP can interfere with S. aureus biofilm. 68 
 69 
2. Materials and methods 70 
2.1. S. aureus isolation and selection of biofilm producing strains 71 
Four field strains of S. aureus (identified as #39, #40, #41, #42) were isolated from raw milk collected 72 
from quarters of Holstein Friesians cows with intramammary infection (IMI) between March and 73 
May 2017 from dairy farms located in northern Italy. For the isolation of S. aureus strains, milk 74 
sample analysis was carried out following the National Mastitis Council guidelines (Adkins et al., 75 
2017). Each milk sample, stored for a maximum of 24 h at +4°C, was thawed at room temperature 76 
and 10 µL were spread on Tryptic Soy agar+5% sheep blood (Microbiol, Italy) for primary isolation 77 
and incubated aerobically at 37°C overnight. Candidate staphylococcal colonies were subcultured on 78 
Mannitol salt agar (Microbiol, Italy) for genus identification. Conventional biochemical tests 79 
5 
 
including catalase, coagulase and oxidase activity confirmed the S. aureus isolation. After the 80 
isolation, the strains were stored in glycerol at -20°C until the use. Biofilm producing capability was 81 
determined by a quantitative method (MtP assay) as previously described  (Stepanović et al., 2007). 82 
The Tryptic Soy Broth (TSB) was supplemented with the type and concentration of carbohydrates 83 
identified in preliminary studies to promote in vitro biofilm formation. Two concentrations of glucose 84 
(1% and 2.5%) and the physiological concentration of lactose found in dairy cow milk (4.7%) were 85 
tested in order to ascertain whether different types and concentration of carbohydrates could influence 86 
biofilm formation, identifying glucose 1% as the ideal supplementation for optimal biofilm formation, 87 
as presented in further details in the “Results” section. 88 
The biofilm forming ability of each of the four field strains was measured by applying Mtp assay 89 
(Stepanović et al., 2007). As negative control, TSB + 1% glucose (TSBg) without bacteria was used. 90 
Each strain was tested in triplicate on three independent plates. Briefly, fresh overnight subcultures 91 
of the strains were 1:100 fold diluted in TSBg and 200 µL were plated. After 24 hours at 37°C, the 92 
supernatant was gently removed and the biofilm was washed with sterile phosphate buffered saline, 93 
fixed with methanol and stained with 2% crystal violet. The absorbance of negative controls was used 94 
to set the optical density cut-off (ODc) as three standard deviations above the mean OD of negative 95 
control. Strains were classified as follow: non-adherent OD≤ ODc; weakly adherent Dc <OD ≤2 X 96 
ODc; moderately adherent ODc <OD ≤4 X ODc; strongly adherent OD> 4X ODc.  97 
 98 
2.2. Molecular typing of S. aureus strains 99 
In order to confirm at molecular level the capability of the selected strains to produce biofilm, 100 
Repetitive Sequence-Polymerase Chain Reaction (RS-PCR) and agr typing were carried out. 101 
Genomic DNA was isolated as previously described (Adwan, 2014). Its concentration and 102 
homogeneity was determined at 260nm and by A260/A280 ratio (Eppendorf BioPhotometer 6131). 103 
The RS-PCR amplifies the 16S-23S rRNA intergenic spacers (Graber, 2016). The primers used and 104 
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amplification conditions were as previously reported (Fournier et al., 2008). To study the agr locus 105 
two duplex PCRs were carried out for determination of agr type (I-IV) as previously reported (Pereyra 106 
et al., 2016). Primers and amplifying conditions (Shopsin et al., 2003) are reported in Table 1. 107 
 108 
2.3 Measurement of AGP capability to regulate biofilm disruption and de novo formation  109 
To determine the capability of AGP to disrupt already established staphylococcal biofilm, a MtP 110 
assay using a volume of 190 µL of bacteria culture (after 1:100 fold final dilution) and 10 µL of AGP 111 
at different concentrations was tested in 96-well flat-bottom plates (Sigma-Aldrich, Italy). 112 
Given the background that the concentration of AGP in milk during acute mastitis is unknown, a 113 
preliminary set of experiments was carried out to determine the working (effective) concentrations of 114 
AGP (Sigma Aldrich, Italy), which was dissolved in sterile PBS (Sigma Aldrich, Italy), starting from 115 
the physiological concentration of AGP in milk (1g/mL) (Ceciliani et al., 2005). The homogeneity 116 
of commercial AGP was confirmed by Sodium Dodecyl Sulphate-PolyAcrylamide Gel 117 
Electrophoresis (SDS-PAGE) and western-blotting on nitrocellulose membrane using an anti-AGP 118 
antibody specific for bovine AGP (Ceciliani et al., 2007b). The following AGP concentration were 119 
used: 1, 10, 50, 100, 300, 900 g/ml. Equivalent concentrations of bovine serum albumin (Sigma-120 
Aldrich - Italy) were used as specificity control, to rule out that the effects were related to non specific 121 
interaction of the protein with biofilm. Following the results of these preliminary experiments, that 122 
are reported in details in the “results” section, two concentrations of 1 and 50 g/mL of AGP were 123 
used.  124 
Two independent Mtp experiments were carried out to measure a) the disruptive ability of AGP 125 
against already established biofilm and b) the capability of AGP to interfere with biofilm formation. 126 
Negative control included TSBg only, while non-treated groups (NT) were bacteria cultivated without 127 
AGP and BSA. The experiments were replicated ten times for each AGP concentration. 128 
a) Measurement of AGP capability to disrupt established biofilm  129 
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Biofilm was grown as previously described (Stepanović et al., 2007) for 24 h at 37°C, after which a 130 
final concentration of 1g/mL and 50 g/mL of AGP was added. Plates were further incubated 131 
aerobically at 37°C for another 24 h, after which the effects of AGP were identified by staining the 132 
biofilm biomass with crystal violet and spectrophotometric reading (Labsystem Multiscan Plus). Each 133 
experiment was replicated three times per strain and three independent plates were used.  134 
b) Measurement of AGP capability to interact with de novo biofilm formation 135 
The MtP assay was applied to study the ability of AGP to inhibit the formation of biofilm, by using 136 
the same concentrations of AGP and albumin as those used for biofilm disruption assay. AGP was 137 
added immediately after bacterial dilution, plates were incubated aerobically at 37°C for 24 h, after 138 
which the AGP effect was quantified by staining with crystal violet and spectrophotometric 139 
reading(Labsystem Multiscan Plus) . Each experiment was replicated three times per strain and three 140 
independent plates were used.  141 
 142 
2.3. RNA extraction and qPCR for detection and quantification of genes related to adhesion and 143 
biofilm formation 144 
The capability of AGP to modulate the expression of genes related to S. aureus adhesion and biofilm 145 
formation was assessed. Each well was washed three times with 200 µL of fresh sterile PBS and 146 
scraped with sterile tips to allow biofilm detachment. The replicates were pooled and transferred in a 147 
sterile 1.5 mL Eppendorf tube, stored at -20°C until RNA extraction. Samples were thawed on ice 148 
and then centrifuged at 10˙000g at 4 °C for 3 min; the pellet was used for further procedures. FastRNA 149 
SPIN Kit for Microbes (MP Biomedicals, France) was used to extract total bacterial RNA following 150 
the manufacturer’s instructions. RNA quantity and purity were checked using NanoDrop 1000 151 
Spectrophotometer (Thermo Scientific - Italy) through 260/208 and 260/230 absorbance ratio. 152 
In order to remove the genomic DNA, 1 µg of RNA was treated with DNase I, RNase-free (Thermo 153 
Scientific, Italy). 154 
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cDNA was obtained after RT-PCR using iScript cDNA Synthesis Kit (Biorad, Italy), following the 155 
manufacture’s procedure. The expression abundance of genes involved in biofilm formation (icaA, 156 
icaD, icaB, and icaC) and adhesive virulence determinants (fnbA, fnbB, clfA, clfB, fib, ebps, eno) was 157 
measured by qPCR. The qPCR was performed on CFX Connect Real-Time PCR Detection System 158 
(Biorad, Italy) in 15 µl total volume, using EvanGreen mix (Biorad, Italy). The sequence and 159 
concentration of primers (Federman et al., 2016) are listed in Table 1. Each sample was tested in 160 
duplicate. No-RT controls and no template controls were performed. Thermal profile was the same 161 
for all targets: 95 °C for 5min, 40 cycle at 95 °C for 10s, 60 °C for 30s and a final step from 55 °C to 162 
95 °C with an increase of 5 °C every 5 seconds for the melting curve. After data normalization with 163 
the reference gene (gyrB), quantification was performed using the Bio-Rad CFX Maestro Software 164 
using the 2-Cq method. The MIQE guidelines (Bustin et al., 2009) were followed. 165 
 166 
2.5 Statistical analysis 167 
Statistical significance in optical densities between groups, on MtP data, were determined by analysis 168 
of variance (ANOVA) using GraphPad Prism v6 (GraphPad Software®, USA), and p-values ≤0.050 169 
were considered significant. The statistical analysis on mRNA abundance data were performed using 170 
XLStat for Windows (Addinsoft, USA). Statistical significance was accepted at p value ≤ 0.050.  171 
Data were tested for normality using the Shapiro-Wilk, Anderson-Darling, Lilliefors and Jarque-Bera 172 
test. Because the data were not normally distributed, nonparametric statistical tests (Kruskall-Wallis 173 
and Dunn test) were applied. Additionally, a heatmap analysis and clustering were performed on 174 
XLStat (Addinsoft, USA), using the average of qPCR data. 175 
 176 
3. Results 177 
3.1. Identification of biofilm producing field strains and biofilm quantitative assay 178 
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The effects of glucose at 1% and 2.5% and lactose at 4.7% were tested to determine the experimental 179 
conditions to test S. aureus biofilm forming capability, as reported in Supplemental Fig. 1. The 180 
analysis of variance and the T-student’s test showed statistical differences (p value ≤ 0.050) between 181 
the two concentrations of glucose and lactose. Although lactose is the most abundant in milk, it was 182 
not able to induce an adequate biofilm production as compared to glucose, which strongly affected 183 
the ability of strains to produce biofilm. Based on these results, 1% of glucose was used as 184 
supplementation ratio for the following in vitro studies. 185 
The strains number #39, #40, #41 and #42 displayed different biofilm producing abilities as reported 186 
in Supplemental Fig. 2. The cut-off point, calculated on negative controls, was set at OD570: 0.22. The 187 
strains #40 and #42 resulted strongly biofilm producers with OD570 values of 1 and 1.4, respectively. 188 
On the contrary, strains #39 and #41 were weak and moderate biofilm producer with OD570 values of 189 
0.3 and 0.51, respectively. Following this second set of preliminary experiments, strains #40 and #42 190 
were selected and included in the following experiments. 191 
 192 
3.2. Molecular typing of biofilm producing strains 193 
The two strains #40 and #42 were classified following amplification of 16S-23S rRNA intergenic 194 
spacers and clustered in the genotype B group. The multiplex PCRs used to characterize the agr locus 195 
provided the evidence that both #40 and #42 strains belong to agr-I group. These results confirmed 196 
at molecular level that the two strains #40 and #42 were able to produce biofilm. 197 
 198 
3.3 AGP interaction with biofilm.  199 
Based on preliminary experiments (Supplemental Fig. 3), two concentration of AGP, namely 1g/ml 200 
and 50g/ml, were selected. The capability of AGP to disrupt biofilm, or inhibit its formation, is 201 
presented in Fig. 1a. AGP caused the partial disruption of already formed biofilm structures of S. 202 
aureus strains #40 and #42 in a strain-related mode. In details, the AGP co-incubation of strain #40 203 
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induced a disruption, which is dose-dependent, and were significant when cultures were incubated 204 
with 50 µg/mL of AGP, as compared with controls or cultures that were co-incubated with AGP at 1 205 
µg/mL. Strain #42 behaved differently. The incubation with 1 µg/mL induced a significant increase 206 
of biofilm formation, whereas with 50 µg/mL induced a disruption. The disruptive activity of AGP 207 
on biofilm formation was found to be specific, since albumin, used at the same concentration, was 208 
not. The biofilm formation was not inhibited by AGP (Fig. 1b). 209 
 210 
3.4.Modulation of the expression of intracellular adhesion cluster (ica) genes  211 
In order to investigate whether the activity of AGP on S. aureus culture also reflected on the 212 
expression of genes related to biofilm formation, a list of genes involved in bacterial adherence and 213 
polysaccharide production was identified, and their abundance was measured by means of a qPCR 214 
approach. The selected targets were detected in all samples. Results are presented in Fig. 2. 215 
AGP differently modulates the expression of target mRNA of strain #40 and #42. In details, an up 216 
regulation of icaA (p = 0.045, ratio AGP[50µg/mL]/NT= 3.5), icaB (p=0.036 ratio AGP[50µg/mL]/NT= 2.9), 217 
icaC (p=0.05, ratio AGP[50µg/mL]/NT= 2.7) and fnbB (p=0.027 ratio AGP[50µg/mL]/NT=2.1) was 218 
observed in strain #40; icaD abundance followed the same trend but the data was not statistically 219 
significant. 220 
The icaC and icaD mRNA abundance levels was also influenced, although with a negative 221 
correlation, by AGP treatment in strain #42 ; in details, icaC (p=0.050, ratio AGP[50µg/mL] / AGP[1µg/mL] 222 
= 0.35) and icaD (p=0.046, ratio AGP[50µg/mL] / AGP[1µg/mL] = 0.34) abundance decreased when 223 
bacteria were incubated with 50g/mL of AGP, as compared with 1g/mL. No significant difference 224 
in abundance of other target genes was detected. 225 
 226 
3.5.Heatmap analysis 227 
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The mRNA abundance of eleven genes was determined and the results are presented as heat map in 228 
Fig. 3; the major changes were detected only in the abundance of genes involved in the biofilm 229 
formation (ica genes), while no relevant modifications were appreciable in genes related to bacterial 230 
adhesion (eno, ebps, clfa, fib, fnbA and fnbB genes).  231 
The two analyzed strains can be sorted in two major clusters; interestingly, control group (0) and 232 
1µg/mL AGP group (1) formed a tighter cluster in both strains, demonstrating that the gene 233 
expression profile was similar between groups 0 and 1 and that it differed from the 50 µg/mL AGP 234 
group. However, the gene expression profile is different between the #40 and #42 strains without 235 
AGP treatment, suggesting the presence of individual features of the strain.  236 
The two strains showed a different response to AGP treatment. The major effects in genes expression 237 
were detected in strain #40, which shown a stronger up regulation of ica and fnbA, genes, involved 238 
in biofilm formation and bacteria adhesion, respectively. No relevant changes were observed in strain 239 
#42 except for fib, whose expression increased after 50µg/mL AGP treatment. 240 
 241 
4. Discussion 242 
The present study investigated for the first time the capability of the acute phase protein AGP to 243 
interact with biofilm of field strains of S. aureus isolated from infected quarters. The results provided 244 
the evidence that AGP could induce the disruption of the biofilm in a dose dependent and in a strain-245 
dependent way even when used at the physiological concentration of AGP in milk (Ceciliani et al., 246 
2005). On the contrary, AGP was not able to interact with the de novo formation of biofilm. It was 247 
also demonstrated that the incubation with AGP modifies the expression rate of genes involved in 248 
biofilm formation in a dose- and a strain- dependent way. 249 
The study was carried out on S .aureus field strains that were isolated from milk of mastitis affected 250 
dairy cows. The molecular typing demonstrated that the two strains that were selected for their 251 
capability to produce biofilm belonged to B genotype (Graber, 2016). Both strains #40 and #42 252 
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revealed the presence of agr-I group, which features high biofilm forming ability in TSB medium 253 
and are penicillin-resistance (Melchior et al., 2009). The genetic characterisation of the agr locus 254 
(Melchior et al., 2009) confirmed at a molecular level the ability of agr-I strains to produce biofilm 255 
in TSBg medium in a strain-to-strain dependant way.  256 
AGP is an immunomodulatory protein, whose function is mostly focused on decreasing collateral 257 
damages related to uncontrolled inflammation (Ceciliani and Lecchi, 2019). In cow, AGP is regarded 258 
as a minor acute phase protein: its serum concentration increases between two- to four-folds during 259 
inflammation. Bovine healthy milk contains AGP, which is produced from mammary gland and likely 260 
exudates from serum during inflammation, at a concentration of 1.3 µg/mL) (Ceciliani et al., 2005). 261 
The amount of milk AGP during mastitis has not been measured so far. We demonstrated in this study 262 
that AGP is effective in disrupting S. aureus biofilm. The molecular mechanism at the background of 263 
AGP activity on biofilm disruption is unknown, but at least two features of AGP structure could be 264 
potentially involved. Firstly, bovine AGP is a 37kDa polypeptide, with a very low pI of 2.7. Secondly, 265 
AGP exposes on its surface a very complex carbohydrate moiety, accounting for more than 42% of 266 
the protein weight, and including as terminal residue of each of the five glycan chain several sialic 267 
acid molecules (Ceciliani and Pocacqua, 2007). The very low pI of AGP may provide a reasonable 268 
background to explain the disruption of S. aureus biofilm, which has been shown to be dependent of 269 
pH values, and it is reduced by acid pH (Zmantar et al., 2010). The high content of sialic acid terminal 270 
residues over the surface of AGP may also be partially related to biofilm disruption. Sialylated 271 
oligosaccharides have been shown to block the adhesion of Helicobacter pylori to epithelial cells 272 
(Simon et al., 1997) and these findings have been recently confirmed in S. aureus as well, where it 273 
was demonstrated that sialylated glycoconjugates could inhibit colonies’ growth (Zeng et al., 2018). 274 
It must also be said that no report about the sensitivity of already developed biofilm to changes of pH 275 
has been reported so far. 276 
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At molecular level, staphylococcal biofilms are encased in an extracellular matrix composed of 277 
extracellular DNA and polysaccharides, the last ones synthesized by enzymes encoded by the 278 
icaABCD operon, whose products include PIA (Arciola et al., 2005), and proteins involved host cell 279 
adhesion, such as fibronectin binding proteins A and B (fnbA and fnbB), that allow cell interaction 280 
with 51 integrins. Therefore, the second step of the present study was to investigate whether the 281 
co-incubation of S. aureus strains reflected on bacterial genes involved in biofilm formation. The 282 
effects of AGP were dose- and strain- dependents, high concentrations of AGP inducing an 283 
upregulation of icaA, icaB and icaC in strain #40 .The effects on Strain #42 are opposite. For Strain 284 
#42, the dysregulation of icaC and icaD genes parallels an increase in biofilm disruption. Moreover, 285 
an apparent upregulation of icaABCD genes, although not statistically significant, corresponds to a 286 
decrease in biofilm disruption. The regulatory mechanism of biofilm is complex and not yet fully 287 
understood. PIA production seems to undergo to strain-to-strain variation (Cue et al., 2012), as 288 
confirmed by the different sensitivity of strain #40 and strain #42 to the challenge with AGP. The 289 
abundance of genes described above is presented as a heatmap analysis in which is possible to 290 
appreciate the substantial differences between the two strain and in terms of levels expression panels. 291 
Although the formation of biofilm is strictly correlated to the production of PIA/PNAG, the present 292 
results are consistent with what has been previously reported in S. epidermidis, e.g. that treatment 293 
with linezolid, and antibiotic choice for anti-Staphylococcus therapy, increases the level of 294 
transcription of gene involved in PIA/PNAG synthesis such as icaA gene in already established 295 
staphylococcal biofilms (Reiter et al., 2014). The main limitation of the present study is the in vitro 296 
experimental approach. In vitro models are necessarily simplistic as compared to in vivo conditions. 297 
In most cases, biofilms include polymicrobial communities, and develop with the support and 298 
presence of complex environment, including serum proteins, inflammatory mediators and adhesion 299 
proteins and specific surfaces(Crawford et al., 2014). Given that the experimental results were 300 
conducted in vitro, it is at least conceivable that genes linked to adhesive matrix molecules did not 301 
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show major changes in expression. It is reasonable to suppose that the expression levels of this genes 302 
can also be modulated by the presence of host molecules which interact with the bacteria adhesion 303 
proteins. 304 
 305 
5. Conclusions 306 
In conclusion, the present study demonstrated for the first time that AGP can disrupt already formed 307 
S. aureus biofilm, but has no inhibitory capability on biofilm synthesis. As a consequence of AGP 308 
activity, a dysregulation of genes involved in biofilm formation was also demonstrated, following a 309 
dose- and strain-dependent pattern. Overall, results of this study provide new insights about AGP 310 
direct antibacterial activity of AGP in bovine milk.  311 
Remains to be demonstrated the molecular bases of AGP mechanism of action, in particular for what 312 
concerns the limited capability to interact with the de novo formation of biofilm.  313 
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Figure captions 439 
Fig. 1: the interaction between AGP and staphylococcal biofilm. 440 
Fig. 1A: quantitative effects of AGP against already formed biofilm. The one-way ANOVA statistical 441 
analysis revealed a significant differences between strain 40 and 42 (p value ≤ 0.001). t-student’s test 442 
was used to compare treatments of each strain (*: p value ≤ 0.05 and 0.01; **: p value ≤ 0.01; ***: p 443 
value ≤ 0.001) 444 
Fig. 1B: quantitate effects of AGP on de novo of biofilm. 445 
No statistical differences were found at both concentrations tested 446 
 447 
Fig. 2: Relative mRNA expression of ica locus and adhesion-related genes. 448 
Relative mRNA abundance of ica genes and genes involved in bacterial adhesion in response to AGP 449 
treatments. The box plots shown the median (line into the box plot), the mean (rhombus shape) and 450 
the upper and lower quartiles (end of the box). The highest and lowest values are shown by the 451 
extreme lines. The statistically significance (p value ≤0.05) is indicated by *. 452 
 453 
Fig. 3: Heatmap and clustering analysis. 454 
Heatmap and clustering analysis shows changes in gene expression profile of eleven genes of S. 455 
aureus (Strain 40 and 42) in response to treatment with AGP protein. A bright red or green represent 456 
a gene strongly down or up regulated respectively. The different shades represent intermediate 457 
situation. The dendrogram, on the top and on the left part of the figure, shows the clusters among the 458 
strains and the genes, respectively. 459 
 460 
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Supplemental Fig. 1 Setup of carbohydrate concentration to supplement TSB.  461 
Effect of different carbohydrate concentrations on biofilm formation of four S. aureus isolates from 462 
mastitic milk. Two concentrations of glucose (1 and 2.5%) and the physiological concentration of 463 
lactose in milk were used (4.7%) to supplement TSB and identify the optimal concentration able to 464 
induce strongest biofilm biomass formation. Analysis of variance revealed significant differences 465 
between the three groups for each strain, T-student’s test revealed the reported statistical differences 466 
(*: p value between 0.05 and 0.01; **: p value < 0.01; ***: p value <0.001).  467 
 468 
Supplemental Fig. 2: Biofilm forming ability of the four S. aureus strains. 469 
Optical densities of #39, #40,#41 and #42 S.aureus strains as measured following the method 470 
previously described (Stepanović et al., 2007). After MtP assay, strain 40 and strain 42 were classified 471 
as strongly biofilm producers, while strain 39 and 41 resulted, respectively, weak and moderate 472 
biofilm producers. 473 
 474 
Supplemental Fig. 3 Setup of AGP concentration to assess its role against staphylococcal biofilm. 475 
Effect of increasing concentrations of AGP on biofilm disruption in # 40 and # 42 S.aureus strains 476 
included in the study (A,B). Albumin was used to exclude aspecific interactions (C,D).  477 
In the second preliminary experiment, starting from 0.1 μg/mL up to 100 μg/mL was created a scaling 478 
down gradient of AGP (E, F) and same concentrations of albumin (G,H). One-way ANOVA test and 479 
T-student’s test were used to determine statistical differences (*: p value between 0.05 and 0.01; **: 480 
p value < 0.01; ***: p value <0.001) 481 
  482 
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Table 1 
 
Primers for adhesion genes (clfA, clfB, ebps, fib, fnbA, fnbB, eno), biofilm genes (icaA, icaD, icaB, 
icaC) and reference gene (gyrB) were as previously reported (Federman et al., 2016). Primers for quorum 
sensing genes (pan-agr, agr-I, agr-II, agr-III, agr-IV) were from Shopsin et al., 2003. 
 
 
 
Gene Sequence (5’-3’) 
Amplicon 
size (bp) 
Primer 
Concetration 
(nM) 
A
d
h
es
io
n
 g
en
e
s 
clfA 
(clumping factor A) 
F ACCCAGGTTCAGATTCTGGCAGCG 
165 350 
R TCGCTGAGTCGGAATCGCTTGCT 
clfB 
(clumping factor B) 
F AACTCCAGGGCCGCCGGTTG 
159 400 
R CCTGAGTCGCTGTCTGAGCCTGAG 
ebps 
(elastin binding protein) 
F GGTGCAGCTGGTGCAATGGGTGT 
191 300 
R GCTGCGCCTCCAGCCAAACCT 
fib 
(fibrinogen binding protein) 
F CGTCAACAGCAGATGCGAGCG 
239 350 
R TGCATCAGTTTTCGCTGCTGGTTT 
fnbA 
(fibronectin bainding protein A) 
F AAATTGGGAGCAGCATCAGT 
121 300 
R GCAGCTGAATTCCCATTTTC 
fnbB 
(fibronection binding protein B) 
F ACGCTCAAGGCGACGGCAAAG 
197 300 
R ACCTTCTGCATGACCTTCTGCACCT 
eno 
(laminin binding protein) 
F TGCCGTAGGTGACGAAGGTGGTT 
195 350 
R GCACCGTGTTCGCCTTCGAACT 
B
io
fi
lm
 g
en
es
 
icaA 
(intercellular adhesion gene) 
F GAGGTAAAGCCAACGCACTC 
151 350 
R CCTGTAACCGCACCAAGTTT 
icaD 
(intercellular adhesion gene) 
F ACCCAACGCTAAAATCATCG 
211 300 
R GCGAAAATGCCCATAGTTTC 
icaB 
(intercellular adhesion gene) 
F ATACCGGCGACTGGGTTTAT 
140 350 
R TTGCAAATCGTGGGTATGTGT 
icaC 
(intercellular adhesion gene) 
F CTTGGGTATTTGCACGCATT 
209 350 
R GCAATATCATGCCGACACCT 
R
ef
er
en
ce
 g
en
e
 
gyrB 
(gyrase subunit B) 
F CGAAGGGGACTCTGCCGGG 
175 350 
R GTCGCCACCGATTCCTGTACC 
q
u
o
ru
m
-s
en
si
n
g
 g
en
es
 
 
pan-agr 
(accessory gene regulator) 
F ATGCACATGGTGCACATGC   
agr-I 
(accessory gene regulator) 
R GTCACAAGTACTATAAGCTGCGAT 440  
agr-II 
(accessory gene regulator) 
R GTATTACTAATTGAAAAGTGCCAT
AGC 
573  
agr-III 
(accessory gene regulator) 
R CTGTTGAAAAAGTCAACTAAAAGC
TC 
406  
agr-IV 
(accessory gene regulator) 
R CGATAATGCCGTAATACCCG 588  
483 
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